It is an metabolite of Ondansetron, is a selective 5-hydroxytryptamine3 receptor antagonist that has been introduced to clinical practice as an antiemetic for cancer treatment-induced and anesthesia-related nausea and vomiting.
Inventory Status
Ready Stock
Please as a distributor to view package sizes and prices